Onderneming Albert Labs International Corp. Deutsche Boerse AG
Aandelen
VB50
CA0127841041
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,006 EUR | 0,00% | 0,00% | +50,00% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - | |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Graeme McFarlane
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
Mike Thompson
BRD | Director/Board Member | - | 11-07-22 |
Richard Skaife
BRD | Director/Board Member | - | - |
Frank J. Lane
BRD | Director/Board Member | 57 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Director/Board Member | - | 11-07-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 74 413 267 | 63 035 215 ( 84,71 %) | 0 | 84,71 % |
Bedrijfsgegevens
Albert Labs International Corp.
6996, Merritt Avenue
V5J 4R6, Burnaby
+778-819-0740
http://www.albertlabs.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,03% | 55,66 mld. | |
-7,53% | 38,98 mld. | |
+36,27% | 38,8 mld. | |
-9,38% | 27,32 mld. | |
+12,31% | 26,29 mld. | |
-16,38% | 20,25 mld. | |
+30,79% | 12,76 mld. | |
+28,57% | 12,18 mld. | |
-0,36% | 12,12 mld. |
- Beurs
- Aandelen
- Koers ABRT
- Koers VB50
- Onderneming Albert Labs International Corp.